Comparison Chart Processa Pharmaceuticals, Inc.
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.570 USD | +11.74% |
|
+19.53% | -10.76% |
| 07-29 | Processa Pharmaceuticals, Inc. acquired Vidya Therapeutics, Inc. for approximately $320 million. | CI |
| 07-29 | Processa Pharmaceuticals, Inc. - M&A Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | +11.74% | +19.53% | -10.76% | -55.69% | -99.92% | 7.07M |  | |  |
- Stock Market
- Stocks
- PCSA Stock
- Charts Processa Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
